Charting the Human Metabolome

Charting the Human Metabolome The success of a database of metabolites has whetted researchers' appetites for more. By Megan Scudellari Courtesy of The Human Metabolome Project After researchers coined the term "metabolomics" in 1998, it appeared in only one or two papers per year. But bolstered by decades of research in analytical chemistry, the field—which focuses on the complete set of small molecule metabolites in a cell, tissue

Written byMegan Scudellari
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

By Megan Scudellari

After researchers coined the term "metabolomics" in 1998, it appeared in only one or two papers per year. But bolstered by decades of research in analytical chemistry, the field—which focuses on the complete set of small molecule metabolites in a cell, tissue, or organism—rapidly adopted its newfound identity: In 2008, over 500 papers mentioned the word "metabolomics." With growing stacks of literature filled with spectral data, concentrations, chemical structures, and more, the field developed an acute need for ways to process and share information.

"In the world of human metabolomics, you didn't have a database, so if someone found a new metabolite, it stayed there in the paper," says David Wishart, a computational biologist at the University of Alberta. So he decided to build one.

In 2004, with funding from the Canadian Foundation for Innovation and Genome Canada, Wishart began the Human Metabolome Database (HMDB), part of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform